Target intelligence / Profile preview

RNA, U6 small nuclear 161, pseudogene (RNU6-161P)

Target
RNU6-161P
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

RNA, U6 small nuclear 161, pseudogene (RNU6-161P) is classified as a **pseudogene** of a U6 small nuclear RNA gene, meaning it is a genetic sequence similar to the functional U6 small nuclear RNA genes but does not encode a functional RNA product itself[1][5]. U6 small nuclear RNAs (snRNAs) are components of the spliceosome, a cellular complex involved in pre-mRNA splicing, but pseudogenes such as RNU6-161P typically lack biological activity and are not known to serve as therapeutic targets or to have direct disease associations[1][5]. There are no documented interactions with drugs, biomarker relevance, or known mechanisms of action; it is generally considered **functionally inactive**[1][5]. ### Key clarifications: - This entry is a **pseudogene** and not a functional target for therapeutic intervention, receptor signaling, enzyme activity, or related pharmacological relevance[1][5]. - There is no evidence this gene is involved in disease or drug action. - There are multiple related U6 small nuclear RNA genes and pseudogenes; only the main functional forms (like RNU6-1) are essential for spliceosome function[2][3], and RNU6-161P is not one of them. If you require information on the **functional U6 small nuclear RNA** or its role in the spliceosome, let me know.

Other names
RNU6-161PRNA, U6 small nuclear 161, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 161, pseudogene (RNU6-161P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 161, pseudogene (RNU6-161P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call